The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
Open accessAbstract
BACKGROUND: GP-BAR1, a member G protein coupled receptor superfamily, is a cell surface bile acid-activated receptor highly expressed in the ileum and colon. In monocytes, ligation of GP-BAR1 by secondary bile acids results in a cAMP-dependent attenuation of cytokine generation. AIMS: To investigate the role GP-BAR1 in regulating intestinal homeostasis and inflammation-driven immune dysfunction in rodent models of colitis. METHODS: Colitis was induced in wild type and GP-BAR1(-/-) mice by DSS and TNBS administration. Potential GP-BAR1 agonists were identified by in silico screening and computational docking studies. RESULTS: GP-BAR1(-/-) mice develop an abnormal morphology of colonic mucous cells and an altered molecular architecture of epithelial tight junctions with increased expression and abnormal subcellular distribution of zonulin 1 resulting in increased intestinal permeability and susceptibility to develop severe colitis in response to DSS at early stage of life. By in silico screening and docking studies we identified ciprofloxacin as a GP-BAR1 ligand. In monocytes, ciprofloxacin increases cAMP concentrations and attenuates TNFα release induced by TLR4 ligation in a GP-BAR1 dependent manner. Treating mice rendered colitic by TNBS with ciprofloxacin and oleanolic acid, a well characterized GP-BAR1 ligand, abrogates signs and symptoms of colitis. Colonic expression of GP-BAR1 mRNA increases in rodent models of colitis and tissues from Crohn's disease patients. Flow cytometry analysis demonstrates that ≈90% of CD14+ cells isolated from the lamina propria of TNBS-treated mice stained positively for GP-BAR1. CONCLUSIONS: GP-BAR1 regulates intestinal barrier structure. Its expression increases in rodent models of colitis and Crohn's disease. Ciprofloxacin is a GP-BAR1 ligand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“changes in the composition of the bile acid pool, an increase in colonic expression of GPBAR1 and a decrease in ileal activity of BAR have all been detected in patients suffering from IBD (Cipriani et al., 2011; Duboc et al., 2013; Lenz et al., 1976; Nijmeijer et al., 2011; Rutgeerts et al., 1979).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Cipriani et al., 2011
In the citing paper
“Gpbar1−/− mice, like their Nr1h4−/− counterparts, develop more severe disease than wildtype controls in several animal models of inflammatory disorder, including colitis, hepatitis and gastritis (Cipriani et al., 2011; C. Guo et al., 2015; Y.-D. Wang et al., 2011).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Cipriani et al., 2011
In the citing paper
“Mice treated with GP-BAR1 agonists (ciprofloxacin and oleanolic acid) abrogated the signs and symptoms of TNBS-induced colitis.117”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [117]
In the citing paper
“Importantly these mice were more susceptible to DSS- or TNBS-induced colitis.117”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Main-chain Bond Lengths and Bond Angles in Protein Structures
Laskowski, R. A., Moss, D. S., & Thornton, J. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1351 · Cited by 1,217
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 383
Winston, J. A., Rivera, A. J., Cai, J., Thanissery, R., Montgomery, S. A., Patterson, A. D., & Theriot, C. M. (2020) · Infection and Immunity · doi:10.1128/iai.00045-20 · Cited by 91
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
Bistoletti, M., Bosi, A., Banfi, D., Giaroni, C., & Baj, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 91
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism
Enright, E. F., Griffin, B. T., Gahan, C. G. M., & Joyce, S. A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.009 · Cited by 91
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Furukawa, M., Moriya, K., Nakayama, J., Inoue, T., Momoda, R., Kawaratani, H., Namisaki, T., Sato, S., Douhara, A., Kaji, K., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13509 · Cited by 86
Stepanov, V., Stankov, K., & Mikov, M. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.802805 · Cited by 85
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases
Dey, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105135 · Cited by 86
Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
Gao, R., Meng, X., Xue, Y., Mao, M., Liu, Y., Tian, X., Sui, B., Li, X., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027212 · Cited by 86
Immunology of bile acids regulated receptors
Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 88
Lewis, N. D., Patnaude, L. A., Pelletier, J., Souza, D., Lukas, S., King, J., Hill, J. D., Stefanopoulos, D. E., Ryan, K. R., Desai, S. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100883 · Cited by 84
Kim, H., & Fang, S. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.140 · Cited by 83
Iyer, N. R., & Corr, S. C. (2021) · Nutrients · doi:10.3390/nu13124259 · Cited by 83
Developments in bile salt based therapies: A critical overview
Donkers, J. M., Abbing, R. L. P. R., & van de Graaf, S. F. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.018 · Cited by 76
Castro, J., Harrington, A. M., Lieu, T., Garcia‐Caraballo, S., Maddern, J., Schober, G., O’Donnell, T. A., Grundy, L., Lumsden, A. L., Miller, P. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131712 · Cited by 78
Bile acids in immunity: Bidirectional mediators between the host and the microbiota
Godlewska, U., Bulanda, E., & Wypych, T. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949033 · Cited by 78
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Microbiota-immune-brain interactions: A lifespan perspective
Ratsika, A., Cruz-Pereira, J. S., Lynch, C. M. K., Clarke, G. A., & Cryan, J. F. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102652 · Cited by 83
The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing
Mroz, M. S., Lajczak, N., Goggins, B. J., Keely, S., & Keely, S. J. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2016 · Cited by 75
Regulation of bile acid receptor activity
Wan, Y. Y., & Sheng, L. (2018) · Liver Research · doi:10.1016/j.livres.2018.09.008 · Cited by 75
TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
Merlen, G., Kahale, N., Bedoya, J. U., Bidault, V., Simerabet, H., Doignon, I., Tanfin, Z., Garcin, I., Pean, N., Gautherot, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316975 · Cited by 72
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 75
Gut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 72
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders
Fiorucci, S., Baldoni, M., Ricci, P., Zampella, A., Distrutti, E., & Biagioli, M. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.04.008 · Cited by 70
Gu, F., Zhu, S., Tang, Y., Liu, X., Jia, M., Malmuthuge, N., Valencak, T. G., McFadden, J. W., Liu, J., & Sun, H. (2023) · Microbiome · doi:10.1186/s40168-023-01492-3 · Cited by 70
Biagioli, M., Carino, A., Fiorucci, C., Marchianò, S., Giorgio, C. D., Roselli, R., Magro, M., Distrutti, E., Bereshchenko, O., Scarpelli, P., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.06.003 · Cited by 68
Calmus, Y., & Poupon, R. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.007 · Cited by 69
Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation
Madella, A. M., van Bergenhenegouwen, J., Garssen, J., Masereeuw, R., & Overbeek, S. A. (2022) · Toxins · doi:10.3390/toxins14090645 · Cited by 70
The role of bile acids in functional GI disorders
Appleby, R., & Walters, J. R. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12370 · Cited by 66
Mencarelli, A., Renga, B., D’Amore, C., Santorelli, C., Graziosi, L., Bruno, A. M., Monti, M. C., Distrutti, E., Cipriani, S., Donini, A., et al. (2013) · Diabetes · doi:10.2337/db13-0299 · Cited by 67
Estrada, J. A., & Contreras, I. (2019) · Nutrients · doi:10.3390/nu11051076 · Cited by 65
Carino, A., Graziosi, L., D’Amore, C., Cipriani, S., Marchianò, S., Marino, E., Zampella, A., Rende, M., Mosci, P., Distrutti, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10477 · Cited by 62
Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function
Ornelas, A., Dowdell, A. S., Lee, J. S., & Colgan, S. P. (2022) · Cells · doi:10.3390/cells11060944 · Cited by 69
Zhou, C., Wang, Y., Li, C., Xie, Z., & Dai, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03330-22 · Cited by 65
Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases
Pan, I., Issac, P. K., Rahman, M. M., Guru, A., & Arockiaraj, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03691-3 · Cited by 62
Burrin, D. G., Stoll, B., & Moore, D. D. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-6331 · Cited by 61
Maroni, L., Agostinelli, L., Saccomanno, S., Pinto, C., Giordano, D. M., Rychlicki, C., Minicis, S. D., Trozzi, L., Bañales, J. M., Melum, E., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.010 · Cited by 59
Regulation of Gastrointestinal Immunity by Metabolites
Gu, B., Kim, M., & Yun, C. (2021) · Nutrients · doi:10.3390/nu13010167 · Cited by 57
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
Mullish, B. H., & Allegretti, J. R. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211017725 · Cited by 61
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease
Suau, R., Pardina, E., Domènech, E., Lorén, V., & Manyé, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab159 · Cited by 60
Gut Microbial Metabolites on Host Immune Responses in Health and Disease
Yoon, J.-H., Do, J.-S., Velankanni, P., Lee, C., & Kwon, H. (2023) · Immune Network · doi:10.4110/in.2023.23.e6 · Cited by 64
Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract
Sharkey, K. A., & Savidge, T. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.12.006 · Cited by 62
Vincenzo, F. D., Puca, P., Lopetuso, L. R., Petito, V., Masi, L., Bartocci, B., Murgiano, M., Felice, M. D., Petronio, L., Gasbarrini, A., et al. (2022) · Nutrients · doi:10.3390/nu14132664 · Cited by 63
The role of bile acid receptor TGR5 in regulating inflammatory signalling
Ye, D., He, J., & He, X. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13361 · Cited by 61
Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology
Staufer, K., Halilbasic, E., Trauner, M., & Kazemi-Shirazi, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813529 · Cited by 58
Fiorucci, S., Zampella, A., Cirino, G., Bucci, M., & Distrutti, E. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00577.2016 · Cited by 57
Carino, A., Marchianò, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801373rr · Cited by 56
Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
Portincasa, P., Ciaula, A. D., Garruti, G., Vacca, M., Angelis, M. D., & Wang, D. Q. ‐. (2020) · Nutrients · doi:10.3390/nu12123709 · Cited by 56
5β-Reduced steroids and human Δ4-3-ketosteroid 5β-reductase (AKR1D1)
Chen, M., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.01.013 · Cited by 55
Bile Acid Signaling in Inflammatory Bowel Disease
Bromke, M. A., & Krzystek‐Korpacka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169096 · Cited by 54
Ward, J. B. J., Mroz, M. S., & Keely, S. J. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12148 · Cited by 57
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases
Stanimirov, B., Stankov, K., & Mikov, M. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60307-6 · Cited by 56
Lin, S., Yang, X., Yuan, P., Yang, J., Wang, P., Zhong, H., Zhang, X., Che, L., Feng, B., Li, J., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01332 · Cited by 55
Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
Chen, Y., & Chen, Y. (2021) · Cancers · doi:10.3390/cancers13164054 · Cited by 54
The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
Hage, R. E., Al-Arawe, N., & Hinterseher, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032399 · Cited by 56
TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
Keitel, V., Reich, M., & Häussinger, D. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8443-x · Cited by 57
Vettorazzi, J. F., Kurauti, M. A., Soares, G. M., Borck, P. C., Ferreira, S. M., Branco, R. C. S., Michelone, L. D. S. L., Boschero, A. C., Costa, J. M., & Carneiro, E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13974-0 · Cited by 54
Bile acids: Key players in inflammatory bowel diseases?
Kriaa, A., Mariaule, V., Jablaoui, A., Rhimi, S., Mkaouar, H., Hernandez, J., Korkmaz, B., Lesner, A., Maguin, E., Aghdassi, A., et al. (2022) · Cells · doi:10.3390/cells11050901 · Cited by 53
New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer
Caliceti, C., Punzo, A., Silla, A., Simoni, P., Roda, G., & Hrelia, S. (2022) · Nutrients · doi:10.3390/nu14142964 · Cited by 51
Ciaula, A. D., Bonfrate, L., Khalil, M., & Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03343-3 · Cited by 53
Lieu, T., Jayaweera, G., & Bunnett, N. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12426 · Cited by 53
Oleanolic Acid Controls Allergic and Inflammatory Responses in Experimental Allergic Conjunctivitis
Córdova, C., Gutiérrez, B., Martínez‐García, C., Martín, R., Gallego‐Muñoz, P., Hernández, M., & Nieto, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091282 · Cited by 52
Gut microbiota and inflammatory bowel disease
Chen, L., & Wang, J. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1540 · Cited by 55
Yang, W., Han, F., Gu, Y., Qu, H. Y., Liu, J., Shen, J., & Leng, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01081-y · Cited by 52
Marroncini, G., Naldi, L., Martinelli, S., & Amedei, A. (2024) · Biomedicines · doi:10.3390/biomedicines12071398 · Cited by 56
The Gut Microbiome and Ferroptosis in MAFLD
Ji, J., Wu, L., Wei, J., Wu, J., & Guo, C. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00136 · Cited by 50
TGR5 in inflammation and cardiovascular disease
Pols, T. W. H. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130279 · Cited by 52
Glycyrrhizic acid prevents enteritis through reduction of NF-κB p65 and p38MAPK expression in rat
Wang, Y., & DU, G.-Q. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4981 · Cited by 50
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Biagioli, M., & Carino, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_225 · Cited by 51
Norovirus encounters in the gut: multifaceted interactions and disease outcomes
Hassan, E., & Baldridge, M. T. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0199-4 · Cited by 52
Biagioli, M., Giorgio, C. D., Massa, C., Marchianò, S., Bellini, R., Bordoni, M., Urbani, G., Roselli, R., Lachi, G., Morretta, E., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117731 · Cited by 54
Tran, C. D., Grice, D. M., Wade, B., Kerr, C. A., Bauer, D. C., Li, D., & Hannan, G. N. (2015) · Future Microbiology · doi:10.2217/fmb.15.54 · Cited by 48
Farnesoid X Receptor: From Medicinal Chemistry To Clinical Applications
Fiorucci, S., Mencarelli, A., Distrutti, E., & Zampella, A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.41 · Cited by 48
Elobixibat for the treatment of constipation
Chedid, V. G., Vijayvargiya, P., & Camilleri, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1522248 · Cited by 49
Zhai, Z., Niu, K., Liu, Y., Lin, C., & Wu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.727681 · Cited by 49
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 50
Romero‐Ramírez, L., & Mey, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179279 · Cited by 50
The gut-brain axis in ischemic stroke: its relevance in pathology and as a therapeutic target
Benakis, C., & Liesz, A. (2022) · Neurological Research and Practice · doi:10.1186/s42466-022-00222-8 · Cited by 52
Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Flynn, C. R., Albaugh, V. L., & Abumrad, N. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.014 · Cited by 48
Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases
Marrone, M. C., & Coccurello, R. (2019) · Biomolecules · doi:10.3390/biom10010012 · Cited by 48
Fryer, R. M., Ng, K. J., Mazurek, S. N., Patnaude, L. A., Skow, D. J., Muthukumarana, A. C., Gilpin, K. E., Dinallo, R. M., Kuzmich, D., Lord, J., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210005 · Cited by 47
Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer
Liu, L., Yang, M., Dong, W., Liu, T., Song, X., Gu, Y., Wang, S., Liu, Y., Abla, Z., Qiao, X., et al. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/6645970 · Cited by 46
Keitel, V., & Häussinger, D. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835f3f14 · Cited by 44
Update on Bile Acid Malabsorption: Finally Ready for Prime Time?
Vijayvargiya, P., & Camilleri, M. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0615-z · Cited by 43
Zhang, Y., Geng, J., Hong, Y., Li, J., Li, S., Sun, R., Xie, Y., Yan, C., Aa, J., & Wang, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00440 · Cited by 43
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Lefort, C., & Cani, P. D. (2021) · Cells · doi:10.3390/cells10020400 · Cited by 44
Chini, M. G., Simone, R. D., Bruno, I., Riccio, R., Dehm, F., Weinigel, C., Barz, D., Werz, O., & Bifulco, G. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.014 · Cited by 42
Mechanisms of oxysterol-induced disease: insights from the biliary system
Kuver, R. (2012) · Clinical Lipidology · doi:10.2217/clp.12.53 · Cited by 42
Oh, B. S., Choi, W. J., Kim, J., Ryu, S. W., Yu, S. Y., Lee, J., Park, S., Kang, S. W., Lee, J., Jung, W. Y., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.736343 · Cited by 41
Jamieson, P. E., Carbonero, F. G., & Stevens, J. F. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100521 · Cited by 49
Review of the Relationships Between Human Gut Microbiome, Diet, and Obesity
Patloka, O., Komprda, T., & Franke, G. (2024) · Nutrients · doi:10.3390/nu16233996 · Cited by 50
Microbiome modulates intestinal homeostasis against inflammatory diseases
Sun, X., & Jia, Z. (2018) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2018.10.014 · Cited by 44
A photo-controlled hyaluronan-based drug delivery nanosystem for cancer therapy
Sun, F., Zhang, P., Liu, Y., Lu, C., Qiu, Y., Mu, H., & Duan, J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.11.005 · Cited by 39
Tang, Y., Wang, J.-P., BAO, W.-M., Yang, J., Ma, L., Yang, J., CHEN, H., Xu, Y., Yang, L., Li, W., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2233 · Cited by 39
Lee, M., Jeong, J., & Kim, D. (2014) · Biomacromolecules · doi:10.1021/bm501272c · Cited by 40
Steroidal Scaffolds as FXR and GPBAR1 Ligands: From Chemistry to Therapeutical Application
Sepe, V., Distrutti, E., Limongelli, V., Fiorucci, S., & Zampella, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.54 · Cited by 37
Li, Y., Yu, Z., Liu, Y., Wang, T., Liu, Y., Bai, Z., Yi, R., Ma, H., Bao, T., Lu, H., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.830781 · Cited by 38
Gustducin couples fatty acid receptors to GLP-1 release in colon
Li, Y., Kokrashvili, Z., Mosinger, B. J., & Margolskee, R. F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2012 · Cited by 40
Song, M., Zhang, F., Fu, Y., Yi, X., Feng, S., Liu, Z., Deng, D., Yang, Q., Yu, M., Zhu, C., et al. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00713-3 · Cited by 44
Bile acid mediated effects on gut integrity and performance of early weaned piglets
de Diego-Cabero, N., Mereu, A., Menoyo, D., Holst, J. J., & Ipharraguerre, I. R. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0425-6 · Cited by 35
Chen, T., Reich, N. W., Bell, N., Finn, P. D., Rodriguez, D. J., Kohler, J. N., Kozuka, K., He, L., Spencer, A. G., Charmot, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00308 · Cited by 37
Gong, L., Liu, F., Liu, J., & Wang, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128835 · Cited by 39
Metadata
- Authors
- Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- University of Salerno (IT)
- Azienda Ospedaliera di Perugia (IT)
- Corresponding author
- Fiorucci, Stefano
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-27
- Volume
- 6
- Issue
- 10
- Pages
- e25637
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3203117
- OpenAlex
- W1970465623
- Cited by
- 382
- References
- 30
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 30 · 2023: 34 · 2022: 45 · 2021: 49 · 2020: 31 · 2019: 29 · 2018: 25 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 23 · 2013: 19 · 2012: 11
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-01-29)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- TGR5, bile acid receptors, colitis, intestinal barrier integrity, tight junctions, intestinal permeability, ciprofloxacin, oleanolic acid, cAMP signaling, TNF-α, TLR4, monocytes, Crohn's disease, DSS-induced colitis, TNBS-induced colitis, lamina propria
- MeSH terms
- Animals, Cholera Toxin, Ciprofloxacin, Colitis, Haptoglobins, Immunity, Intestinal Mucosa, Ligands, Permeability, Protein Precursors, Mice, Knockout, Tight Junctions, Receptors, G-Protein-Coupled, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
